E N D
1. Transdermal Pain Management Courtney Yee, Pharm.D.Apothecary Shops of Arizona
Introduce topicIntroduce topic
2. Objectives Introduction to compounding pharmacies
Describe the benefits of transdermal pain management
Discuss specific medications for use in transdermal gels
Discuss specific formulas for different conditions
3. Compounding, v. 1. The custom-making of medications by a pharmacist on the prescription order of a physician.
Compounding is the traditional method of preparing customized medications to help meet unique physician and patient needs.
Its our goal as Compounding pharmacists to provide innovative patient care. This may involve compounding a preservative free eye drop in a sterile compounding lab, making an injection for impotency, preparing medications for veterinarians, or providing natural hormone replacement therapy.
compounding pharmacists ultimate goal in preparing customized medications is to help the physician and patient achieve a more positive therapeutic outcome.
Compounding is the traditional method of preparing customized medications to help meet unique physician and patient needs.
Its our goal as Compounding pharmacists to provide innovative patient care. This may involve compounding a preservative free eye drop in a sterile compounding lab, making an injection for impotency, preparing medications for veterinarians, or providing natural hormone replacement therapy.
compounding pharmacists ultimate goal in preparing customized medications is to help the physician and patient achieve a more positive therapeutic outcome.
4. The Paradox By going back to the ancient art, modern compounding offers the freedom & flexibility of more therapeutic options to choose from. Compounding allows you to do what your colleagues were able to do 100 years ago customize the medicine to each individual patients exact needs. Today, you amazing high-tech, bio-tech diagnostic equipment to allow you to hone in on the exact diagnosis and then when it comes to treating that exact diagnosis, your restricted to the medication typically being available only in 1 or 2 strengths and only in tablets. So now you have to fit the patient to the closest medication, instead of the exact medication at the exact dose, in the best dosage form available.Compounding allows you to do what your colleagues were able to do 100 years ago customize the medicine to each individual patients exact needs. Today, you amazing high-tech, bio-tech diagnostic equipment to allow you to hone in on the exact diagnosis and then when it comes to treating that exact diagnosis, your restricted to the medication typically being available only in 1 or 2 strengths and only in tablets. So now you have to fit the patient to the closest medication, instead of the exact medication at the exact dose, in the best dosage form available.
5. Compounding allows you to: Prescribe what is BEST for each individual patient
Not just what is COMMERCIALLY AVAILABLE for your patient.
6. Goals of Transdermal Therapy To deliver local concentrations of medication higher than possible through the oral or parenteral routes
Reduce side effects and drug interactions through avoidance of systemic absorption and renal/hepatic exposure Higher concentrations
Fewer side effects
Higher concentrations
Fewer side effects
7. Transdermal Advantages Little to no GI upset with NSAIDS
Local action, site specific
Easy to titrate to individual patient
Fast onset of action
High drug concentrations in the tissue that requires analgesia GI upset
history of PUD, GERD, elderly
Gastric bypass Dr. Blackstone storyGI upset
history of PUD, GERD, elderly
Gastric bypass Dr. Blackstone story
8. Pain medications used in transdermal preparations Ketoprofen
Ibuprofen
Lidocaine
Cyclobenzaprine
Guaifenesin
Ketamine
Diclofenac
Amitriptyline
Carbamazepine
Gabapentin
Clonidine
Nifedepine
Baclofen
Morphine Also, medications are not new to anyone
they are medications that are widely used in other forms such as IV or PO.Also, medications are not new to anyone
they are medications that are widely used in other forms such as IV or PO.
9. Anti-inflammatory Agents Inhibit Prostaglandin synthesis
Decrease sensitivity of vessels to bradykinin and histamine
Ketoprofen (10-20%)
Diclofenac (2-5%)
Ibuprofen (10-20%)
Piroxicam (0.5-3%) The NSAIDS inhibit prostaglandin synthetase which prevents the conversion of PGG2 and PGH2 to PGE2 and PGF2alpha which are responsible for pain and vasodilation. The NSAIDS inhibit prostaglandin synthetase which prevents the conversion of PGG2 and PGH2 to PGE2 and PGF2alpha which are responsible for pain and vasodilation.
10. Muscle Relaxants/Spasmolytics Baclofen (2-5%)
Cyclobenzaprine (1-4%)
Structurally related to TCA
May also act as NMDA partial agonist, NE and 5-HT reuptake inhibitor
Guaifenesin (10%)
Depresses or blocks nerve impulse transmission
11. Local Anesthetics Prevent generation and conduction of nerve impulses
Lidocaine 2-10%
Tetracaine 2-10 %
Bupivicaine 0.5-0.75 % Act by preventing both the generation and conduction of nerve impulses by reducing or preventing large transient increases in the permeability of the membrane to sodium ions. The blockade of sodium channels by these agents blocks nociceptive transmission, interupts sympathetic reflexes and prevents increased skeletal muscle activity which helps relieve painAct by preventing both the generation and conduction of nerve impulses by reducing or preventing large transient increases in the permeability of the membrane to sodium ions. The blockade of sodium channels by these agents blocks nociceptive transmission, interupts sympathetic reflexes and prevents increased skeletal muscle activity which helps relieve pain
12. Local Pain Problems That Can be Solved: Inflammation
Muscle spasms
Chronic Back Pain
Neuropathy Plantar Fasciitis
Tendonitis
Carpal Tunnel
RSD
13. Evidence Based Medicine Quantitative systematic review of topically applied NSAIDs
BMJ, Jan 31, 1998
86 randomized, controlled trials
10,160 patients
14. BMJ Review Conclusions: Topical NSAIDs are effective in relieving pain in acute and chronic conditions
Adverse events & withdrawal from the studies related to the drug had a low incidence and were no different from placebo. The study shows the results were exactly what was expected
local efficacy with little side effectThe study shows the results were exactly what was expected
local efficacy with little side effect
15. More Evidence of Safety of Transdermal NSAIDs
BMJ Post-Marketing Survey
23,590 pts using topical NSAIDs
6 cases of definite or probable adverse GI events
(BMJ 1995;311:22-6)
BlackstoneBlackstone
16. Kinetics Explains Safety Oral Ketoprofen ?? 60% bioavailabilty
vs
Transdermal ?? <5% bioavailability
Pharmacokinetics of Ketoprofen in man after repeated percutaneous administration Arzneimeittelforshung, 1989;39 7:812-815
17. Kinetics Explains Local Efficacy Application of ketoprofen to knee of pts about to undergo knee surgery showed ketoprofen concentrations 100 times greater in: synovial fluid, intra-articular adipose tissue, and capsular tissue than in the blood.
Antirheumatic Drug Concentrations in Human Synovial Fluid and Synovial Tissue Clin Pharmacokinetics 8:496-522(1983)
18. Formulas for Inflammation: Ketoprofen Gel
10-20% in PLO
4% with DMSO/n-decylmethylsulfoxide
Ketoprofen/Lidocaine Gel
20/10 in PLO
4%/2% with DMSO/n-decylmethylsulfoxide
KICK Gel Diclofenac, piroxicam longer actingDiclofenac, piroxicam longer acting
19. Formulas for Muscle Spasms Ketoprofen/baclofen Gel
Baclofen 2-5%
4%/2% with DMSO/N-decylmethylsulfoxide
Ketoprofen/guaifenesin Gel
Guaifenesin 10%
20. Formulas for Neuropathy NeuroGel
Ketoprofen 20%
Amitriptyline 5%
Carbamazepine 2%
Diabetic Neuropathy
Add nifedipine 2% KetoGabaClon Gel
Ketoprofen 20%
Gabapentin 6%
Clonidine 0.2%
KetaGabaClon Gel
Ketamine 10% Nifedipine
- non-NMDA calcium channel blocker
Provides direct vasodilatory effect on vessels, nerve conduction, hypoxic resistance and capillary density
additive protective effect of topical ketamine and nifedipine in combinationNifedipine
- non-NMDA calcium channel blocker
Provides direct vasodilatory effect on vessels, nerve conduction, hypoxic resistance and capillary density
additive protective effect of topical ketamine and nifedipine in combination
21. Transdermal Drug Delivery:A More Conservative Approach
Lower doses being used
Drugs being delivered to site of action
Fewer side-effects
Fewer drug interactions
Better/Faster efficacy
22. Keys to Positive Outcomes Multiple ingredients with complementary modes of action
NMDA antagonist, glutamate/AMPA antagonist, alpha-2 or GABA-b agonist
Base that is penetration enhancing
PLO, Lipoderm
Evaluation Apply at 6-8 hour intervals and up to every 2 hours as needed in between
Additional medication with different modes of action can be added within 1-2 weeks and dose escalation and evaluation should be repeatedApply at 6-8 hour intervals and up to every 2 hours as needed in between
Additional medication with different modes of action can be added within 1-2 weeks and dose escalation and evaluation should be repeated
23. The Bottom Line:
Compounding can be a cost-effective key to solving many common problems as well as individualizing a patients therapy.
24. Contact Information Apothecary Shop of Scottsdale
9777 N 91st Street #102
Scottsdale, AZ 85258
Pharmacy 480-451-3771
Fax 480-451-3503
25. Thank You
Thanks to doctor ____ for inviting me to speak.Thanks to doctor ____ for inviting me to speak.